Nephroprotection and chemotherapy sensitivity impact of metformin during cisplatin therapy; an updated review

• Egile Nagusiak: Mohsen Akhavan Sepahi (Egilea), Sarvenaz Mehrabi (Egilea), Rohollah Valizadeh (Egilea), Steven James Kellner (Egilea), Azin Mirzazadeh (Egilea), Semko Ebrahimi (Egilea)
• Formatua: Liburua
• Argitaratua: Society of Diabetic Nephropathy Prevention, 2019-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Chemotherapy has been accepted as the most common choice for cancer treatment. However, chemotherapy-induced toxicity and chemotherapy resistance are the two challenging barriers to the treatment. Metformin is a safe, inexpensive, and the first line drug to treat type II diabetes. It has also a sign...